nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ABCB1—ovarian cancer	0.315	1	CbGaD
Mirabegron—SLCO1A2—Chlorambucil—ovarian cancer	0.253	0.496	CbGbCtD
Mirabegron—ABCB1—Topotecan—ovarian cancer	0.0473	0.0929	CbGbCtD
Mirabegron—ABCB1—Vinorelbine—ovarian cancer	0.0334	0.0654	CbGbCtD
Mirabegron—CYP2D6—Vinorelbine—ovarian cancer	0.0314	0.0616	CbGbCtD
Mirabegron—CYP3A4—Topotecan—ovarian cancer	0.0284	0.0556	CbGbCtD
Mirabegron—ABCB1—Paclitaxel—ovarian cancer	0.0234	0.046	CbGbCtD
Mirabegron—CYP3A4—Vinorelbine—ovarian cancer	0.02	0.0392	CbGbCtD
Mirabegron—ABCB1—Docetaxel—ovarian cancer	0.0169	0.0332	CbGbCtD
Mirabegron—CYP3A4—Paclitaxel—ovarian cancer	0.014	0.0275	CbGbCtD
Mirabegron—ABCB1—Doxorubicin—ovarian cancer	0.0126	0.0248	CbGbCtD
Mirabegron—CYP2D6—Doxorubicin—ovarian cancer	0.0119	0.0233	CbGbCtD
Mirabegron—CYP3A4—Docetaxel—ovarian cancer	0.0102	0.0199	CbGbCtD
Mirabegron—BCHE—diaphragm—ovarian cancer	0.00793	0.285	CbGeAlD
Mirabegron—CYP3A4—Doxorubicin—ovarian cancer	0.00757	0.0148	CbGbCtD
Mirabegron—ADRB3—female reproductive system—ovarian cancer	0.00196	0.0702	CbGeAlD
Mirabegron—ADRB3—female gonad—ovarian cancer	0.00178	0.0639	CbGeAlD
Mirabegron—ORM1—endometrium—ovarian cancer	0.0011	0.0393	CbGeAlD
Mirabegron—BCHE—myometrium—ovarian cancer	0.000965	0.0346	CbGeAlD
Mirabegron—ORM1—female reproductive system—ovarian cancer	0.000907	0.0325	CbGeAlD
Mirabegron—ORM1—bone marrow—ovarian cancer	0.000856	0.0307	CbGeAlD
Mirabegron—BCHE—uterine cervix—ovarian cancer	0.000751	0.0269	CbGeAlD
Mirabegron—BCHE—endometrium—ovarian cancer	0.000679	0.0244	CbGeAlD
Mirabegron—SLCO1A2—testis—ovarian cancer	0.000646	0.0232	CbGeAlD
Mirabegron—ALB—testis—ovarian cancer	0.000642	0.023	CbGeAlD
Mirabegron—BCHE—uterus—ovarian cancer	0.000626	0.0224	CbGeAlD
Mirabegron—BCHE—female reproductive system—ovarian cancer	0.000562	0.0202	CbGeAlD
Mirabegron—BCHE—bone marrow—ovarian cancer	0.000531	0.019	CbGeAlD
Mirabegron—ORM1—lymph node—ovarian cancer	0.000531	0.019	CbGeAlD
Mirabegron—BCHE—vagina—ovarian cancer	0.000509	0.0182	CbGeAlD
Mirabegron—Skin disorder—Topotecan—ovarian cancer	0.000485	0.0033	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000484	0.0033	CcSEcCtD
Mirabegron—Fatigue—Chlorambucil—ovarian cancer	0.000483	0.00329	CcSEcCtD
Mirabegron—Tachycardia—Melphalan—ovarian cancer	0.000477	0.00325	CcSEcCtD
Mirabegron—Skin disorder—Melphalan—ovarian cancer	0.000475	0.00323	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.000469	0.0032	CcSEcCtD
Mirabegron—ALB—lymph node—ovarian cancer	0.000465	0.0167	CbGeAlD
Mirabegron—Palpitations—Vinorelbine—ovarian cancer	0.000462	0.00315	CcSEcCtD
Mirabegron—ABCB1—myometrium—ovarian cancer	0.00046	0.0165	CbGeAlD
Mirabegron—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000458	0.00312	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000455	0.0031	CcSEcCtD
Mirabegron—BCHE—testis—ovarian cancer	0.000454	0.0163	CbGeAlD
Mirabegron—Hypertension—Vinorelbine—ovarian cancer	0.000452	0.00308	CcSEcCtD
Mirabegron—Infestation—Paclitaxel—ovarian cancer	0.00045	0.00307	CcSEcCtD
Mirabegron—Infestation NOS—Paclitaxel—ovarian cancer	0.00045	0.00307	CcSEcCtD
Mirabegron—Cystitis noninfective—Epirubicin—ovarian cancer	0.000449	0.00306	CcSEcCtD
Mirabegron—Breast disorder—Docetaxel—ovarian cancer	0.000448	0.00305	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.000446	0.00304	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000446	0.00304	CcSEcCtD
Mirabegron—Urticaria—Chlorambucil—ovarian cancer	0.000445	0.00303	CcSEcCtD
Mirabegron—Arthralgia—Vinorelbine—ovarian cancer	0.000445	0.00303	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000445	0.00303	CcSEcCtD
Mirabegron—Cystitis—Epirubicin—ovarian cancer	0.000444	0.00303	CcSEcCtD
Mirabegron—Abdominal pain—Chlorambucil—ovarian cancer	0.000443	0.00302	CcSEcCtD
Mirabegron—Nasopharyngitis—Docetaxel—ovarian cancer	0.000443	0.00302	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000442	0.00301	CcSEcCtD
Mirabegron—ABCB1—embryo—ovarian cancer	0.000442	0.0159	CbGeAlD
Mirabegron—Dyspepsia—Topotecan—ovarian cancer	0.000439	0.00299	CcSEcCtD
Mirabegron—Urinary tract infection—Paclitaxel—ovarian cancer	0.000438	0.00298	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000437	0.00298	CcSEcCtD
Mirabegron—Vaginal infection—Epirubicin—ovarian cancer	0.000434	0.00296	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000431	0.00294	CcSEcCtD
Mirabegron—Fatigue—Topotecan—ovarian cancer	0.00043	0.00293	CcSEcCtD
Mirabegron—Dyspepsia—Melphalan—ovarian cancer	0.00043	0.00293	CcSEcCtD
Mirabegron—Constipation—Topotecan—ovarian cancer	0.000427	0.00291	CcSEcCtD
Mirabegron—Dry eye—Epirubicin—ovarian cancer	0.000425	0.0029	CcSEcCtD
Mirabegron—Infection—Vinorelbine—ovarian cancer	0.000424	0.00289	CcSEcCtD
Mirabegron—Sinusitis—Paclitaxel—ovarian cancer	0.000422	0.00288	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000422	0.00287	CcSEcCtD
Mirabegron—Fatigue—Melphalan—ovarian cancer	0.000421	0.00287	CcSEcCtD
Mirabegron—Tachycardia—Vinorelbine—ovarian cancer	0.000417	0.00284	CcSEcCtD
Mirabegron—Neoplasm—Epirubicin—ovarian cancer	0.000416	0.00283	CcSEcCtD
Mirabegron—Bladder pain—Epirubicin—ovarian cancer	0.000416	0.00283	CcSEcCtD
Mirabegron—Cystitis noninfective—Doxorubicin—ovarian cancer	0.000416	0.00283	CcSEcCtD
Mirabegron—Skin disorder—Vinorelbine—ovarian cancer	0.000415	0.00282	CcSEcCtD
Mirabegron—Cystitis—Doxorubicin—ovarian cancer	0.000411	0.0028	CcSEcCtD
Mirabegron—Gastrointestinal pain—Topotecan—ovarian cancer	0.000408	0.00278	CcSEcCtD
Mirabegron—Rhinitis—Paclitaxel—ovarian cancer	0.000405	0.00276	CcSEcCtD
Mirabegron—Asthenia—Chlorambucil—ovarian cancer	0.000402	0.00274	CcSEcCtD
Mirabegron—Vaginal infection—Doxorubicin—ovarian cancer	0.000402	0.00274	CcSEcCtD
Mirabegron—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000399	0.00272	CcSEcCtD
Mirabegron—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000397	0.00271	CcSEcCtD
Mirabegron—Pruritus—Chlorambucil—ovarian cancer	0.000397	0.0027	CcSEcCtD
Mirabegron—Urticaria—Topotecan—ovarian cancer	0.000396	0.0027	CcSEcCtD
Mirabegron—Urethral disorder—Paclitaxel—ovarian cancer	0.000396	0.0027	CcSEcCtD
Mirabegron—Abdominal pain—Topotecan—ovarian cancer	0.000395	0.00269	CcSEcCtD
Mirabegron—Dry eye—Doxorubicin—ovarian cancer	0.000393	0.00268	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000389	0.00265	CcSEcCtD
Mirabegron—Urticaria—Melphalan—ovarian cancer	0.000388	0.00264	CcSEcCtD
Mirabegron—Bladder pain—Doxorubicin—ovarian cancer	0.000385	0.00262	CcSEcCtD
Mirabegron—Neoplasm—Doxorubicin—ovarian cancer	0.000385	0.00262	CcSEcCtD
Mirabegron—Diarrhoea—Chlorambucil—ovarian cancer	0.000384	0.00261	CcSEcCtD
Mirabegron—Erythema multiforme—Paclitaxel—ovarian cancer	0.000382	0.0026	CcSEcCtD
Mirabegron—Infestation—Docetaxel—ovarian cancer	0.000382	0.0026	CcSEcCtD
Mirabegron—Infestation NOS—Docetaxel—ovarian cancer	0.000382	0.0026	CcSEcCtD
Mirabegron—CYP3A4—female reproductive system—ovarian cancer	0.000379	0.0136	CbGeAlD
Mirabegron—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000378	0.00258	CcSEcCtD
Mirabegron—Eye disorder—Paclitaxel—ovarian cancer	0.000378	0.00257	CcSEcCtD
Mirabegron—Cardiac disorder—Paclitaxel—ovarian cancer	0.000375	0.00256	CcSEcCtD
Mirabegron—Vascular purpura—Epirubicin—ovarian cancer	0.000373	0.00254	CcSEcCtD
Mirabegron—CYP2D6—female reproductive system—ovarian cancer	0.000373	0.0134	CbGeAlD
Mirabegron—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000369	0.00251	CcSEcCtD
Mirabegron—Fatigue—Vinorelbine—ovarian cancer	0.000368	0.00251	CcSEcCtD
Mirabegron—Constipation—Vinorelbine—ovarian cancer	0.000365	0.00249	CcSEcCtD
Mirabegron—ABCB1—epithelium—ovarian cancer	0.000361	0.0129	CbGeAlD
Mirabegron—Asthenia—Topotecan—ovarian cancer	0.000358	0.00244	CcSEcCtD
Mirabegron—ABCB1—uterine cervix—ovarian cancer	0.000358	0.0128	CbGeAlD
Mirabegron—Pruritus—Topotecan—ovarian cancer	0.000353	0.00241	CcSEcCtD
Mirabegron—Asthenia—Melphalan—ovarian cancer	0.000351	0.00239	CcSEcCtD
Mirabegron—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000349	0.00238	CcSEcCtD
Mirabegron—Purpura—Epirubicin—ovarian cancer	0.000347	0.00236	CcSEcCtD
Mirabegron—Pruritus—Melphalan—ovarian cancer	0.000346	0.00236	CcSEcCtD
Mirabegron—Vascular purpura—Doxorubicin—ovarian cancer	0.000345	0.00235	CcSEcCtD
Mirabegron—Rhinitis—Docetaxel—ovarian cancer	0.000343	0.00234	CcSEcCtD
Mirabegron—Diarrhoea—Topotecan—ovarian cancer	0.000341	0.00233	CcSEcCtD
Mirabegron—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000341	0.00232	CcSEcCtD
Mirabegron—ABCB1—decidua—ovarian cancer	0.000341	0.0122	CbGeAlD
Mirabegron—Back pain—Paclitaxel—ovarian cancer	0.00034	0.00232	CcSEcCtD
Mirabegron—Urticaria—Vinorelbine—ovarian cancer	0.000339	0.00231	CcSEcCtD
Mirabegron—CYP2D6—female gonad—ovarian cancer	0.000339	0.0122	CbGeAlD
Mirabegron—Urinary tract disorder—Docetaxel—ovarian cancer	0.000338	0.0023	CcSEcCtD
Mirabegron—Abdominal pain—Vinorelbine—ovarian cancer	0.000337	0.0023	CcSEcCtD
Mirabegron—Connective tissue disorder—Docetaxel—ovarian cancer	0.000337	0.00229	CcSEcCtD
Mirabegron—Urethral disorder—Docetaxel—ovarian cancer	0.000336	0.00229	CcSEcCtD
Mirabegron—Diarrhoea—Melphalan—ovarian cancer	0.000334	0.00228	CcSEcCtD
Mirabegron—Osteoarthritis—Epirubicin—ovarian cancer	0.000334	0.00228	CcSEcCtD
Mirabegron—Nausea—Chlorambucil—ovarian cancer	0.000333	0.00227	CcSEcCtD
Mirabegron—Vision blurred—Paclitaxel—ovarian cancer	0.000332	0.00226	CcSEcCtD
Mirabegron—Dizziness—Topotecan—ovarian cancer	0.00033	0.00225	CcSEcCtD
Mirabegron—BCHE—lymph node—ovarian cancer	0.000329	0.0118	CbGeAlD
Mirabegron—Erythema multiforme—Docetaxel—ovarian cancer	0.000324	0.00221	CcSEcCtD
Mirabegron—ABCB1—endometrium—ovarian cancer	0.000324	0.0116	CbGeAlD
Mirabegron—Purpura—Doxorubicin—ovarian cancer	0.000321	0.00218	CcSEcCtD
Mirabegron—Eye disorder—Docetaxel—ovarian cancer	0.00032	0.00218	CcSEcCtD
Mirabegron—Cardiac disorder—Docetaxel—ovarian cancer	0.000318	0.00217	CcSEcCtD
Mirabegron—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000315	0.00215	CcSEcCtD
Mirabegron—Rash—Topotecan—ovarian cancer	0.000315	0.00214	CcSEcCtD
Mirabegron—Dermatitis—Topotecan—ovarian cancer	0.000314	0.00214	CcSEcCtD
Mirabegron—Headache—Topotecan—ovarian cancer	0.000313	0.00213	CcSEcCtD
Mirabegron—Palpitations—Paclitaxel—ovarian cancer	0.000311	0.00212	CcSEcCtD
Mirabegron—Osteoarthritis—Doxorubicin—ovarian cancer	0.000309	0.00211	CcSEcCtD
Mirabegron—Rash—Melphalan—ovarian cancer	0.000308	0.0021	CcSEcCtD
Mirabegron—Dermatitis—Melphalan—ovarian cancer	0.000308	0.0021	CcSEcCtD
Mirabegron—Asthenia—Vinorelbine—ovarian cancer	0.000306	0.00209	CcSEcCtD
Mirabegron—Hypertension—Paclitaxel—ovarian cancer	0.000304	0.00207	CcSEcCtD
Mirabegron—Pruritus—Vinorelbine—ovarian cancer	0.000302	0.00206	CcSEcCtD
Mirabegron—Breast disorder—Epirubicin—ovarian cancer	0.000302	0.00206	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000301	0.00205	CcSEcCtD
Mirabegron—CYP2D6—testis—ovarian cancer	0.000301	0.0108	CbGeAlD
Mirabegron—ABCB1—gonad—ovarian cancer	0.0003	0.0108	CbGeAlD
Mirabegron—Arthralgia—Paclitaxel—ovarian cancer	0.0003	0.00204	CcSEcCtD
Mirabegron—Nasopharyngitis—Epirubicin—ovarian cancer	0.000299	0.00203	CcSEcCtD
Mirabegron—ABCB1—uterus—ovarian cancer	0.000298	0.0107	CbGeAlD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000297	0.00203	CcSEcCtD
Mirabegron—Nausea—Topotecan—ovarian cancer	0.000296	0.00202	CcSEcCtD
Mirabegron—Gastritis—Epirubicin—ovarian cancer	0.000296	0.00201	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000295	0.00201	CcSEcCtD
Mirabegron—Dry mouth—Paclitaxel—ovarian cancer	0.000293	0.002	CcSEcCtD
Mirabegron—Diarrhoea—Vinorelbine—ovarian cancer	0.000292	0.00199	CcSEcCtD
Mirabegron—Abdominal distension—Epirubicin—ovarian cancer	0.000291	0.00198	CcSEcCtD
Mirabegron—Nausea—Melphalan—ovarian cancer	0.00029	0.00198	CcSEcCtD
Mirabegron—Influenza—Epirubicin—ovarian cancer	0.000289	0.00197	CcSEcCtD
Mirabegron—Back pain—Docetaxel—ovarian cancer	0.000288	0.00197	CcSEcCtD
Mirabegron—Infection—Paclitaxel—ovarian cancer	0.000285	0.00194	CcSEcCtD
Mirabegron—Dizziness—Vinorelbine—ovarian cancer	0.000282	0.00192	CcSEcCtD
Mirabegron—Tachycardia—Paclitaxel—ovarian cancer	0.00028	0.00191	CcSEcCtD
Mirabegron—Breast disorder—Doxorubicin—ovarian cancer	0.000279	0.0019	CcSEcCtD
Mirabegron—Skin disorder—Paclitaxel—ovarian cancer	0.000279	0.0019	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000278	0.0019	CcSEcCtD
Mirabegron—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000276	0.00188	CcSEcCtD
Mirabegron—Gastritis—Doxorubicin—ovarian cancer	0.000274	0.00186	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000273	0.00186	CcSEcCtD
Mirabegron—Rash—Vinorelbine—ovarian cancer	0.000269	0.00183	CcSEcCtD
Mirabegron—Dermatitis—Vinorelbine—ovarian cancer	0.000269	0.00183	CcSEcCtD
Mirabegron—Abdominal distension—Doxorubicin—ovarian cancer	0.000269	0.00183	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000268	0.00183	CcSEcCtD
Mirabegron—ABCB1—female reproductive system—ovarian cancer	0.000268	0.00961	CbGeAlD
Mirabegron—Headache—Vinorelbine—ovarian cancer	0.000267	0.00182	CcSEcCtD
Mirabegron—Influenza—Doxorubicin—ovarian cancer	0.000267	0.00182	CcSEcCtD
Mirabegron—Palpitations—Docetaxel—ovarian cancer	0.000264	0.0018	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000262	0.00178	CcSEcCtD
Mirabegron—Hypertension—Docetaxel—ovarian cancer	0.000257	0.00175	CcSEcCtD
Mirabegron—Infestation NOS—Epirubicin—ovarian cancer	0.000257	0.00175	CcSEcCtD
Mirabegron—Infestation—Epirubicin—ovarian cancer	0.000257	0.00175	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000255	0.00174	CcSEcCtD
Mirabegron—Arthralgia—Docetaxel—ovarian cancer	0.000254	0.00173	CcSEcCtD
Mirabegron—Nausea—Vinorelbine—ovarian cancer	0.000254	0.00173	CcSEcCtD
Mirabegron—ABCB1—bone marrow—ovarian cancer	0.000253	0.00908	CbGeAlD
Mirabegron—Dyspepsia—Paclitaxel—ovarian cancer	0.000253	0.00172	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000252	0.00172	CcSEcCtD
Mirabegron—Urinary tract infection—Epirubicin—ovarian cancer	0.00025	0.0017	CcSEcCtD
Mirabegron—Dry mouth—Docetaxel—ovarian cancer	0.000248	0.00169	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000248	0.00169	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000248	0.00169	CcSEcCtD
Mirabegron—Fatigue—Paclitaxel—ovarian cancer	0.000248	0.00169	CcSEcCtD
Mirabegron—Constipation—Paclitaxel—ovarian cancer	0.000246	0.00167	CcSEcCtD
Mirabegron—ABCB1—female gonad—ovarian cancer	0.000244	0.00875	CbGeAlD
Mirabegron—ABCB1—vagina—ovarian cancer	0.000242	0.0087	CbGeAlD
Mirabegron—Infection—Docetaxel—ovarian cancer	0.000242	0.00165	CcSEcCtD
Mirabegron—Sinusitis—Epirubicin—ovarian cancer	0.000241	0.00165	CcSEcCtD
Mirabegron—Infestation NOS—Doxorubicin—ovarian cancer	0.000238	0.00162	CcSEcCtD
Mirabegron—Infestation—Doxorubicin—ovarian cancer	0.000238	0.00162	CcSEcCtD
Mirabegron—Tachycardia—Docetaxel—ovarian cancer	0.000238	0.00162	CcSEcCtD
Mirabegron—Skin disorder—Docetaxel—ovarian cancer	0.000236	0.00161	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000236	0.00161	CcSEcCtD
Mirabegron—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000235	0.0016	CcSEcCtD
Mirabegron—Rhinitis—Epirubicin—ovarian cancer	0.000232	0.00158	CcSEcCtD
Mirabegron—Urinary tract infection—Doxorubicin—ovarian cancer	0.000232	0.00158	CcSEcCtD
Mirabegron—Urinary tract disorder—Epirubicin—ovarian cancer	0.000228	0.00155	CcSEcCtD
Mirabegron—Urticaria—Paclitaxel—ovarian cancer	0.000228	0.00155	CcSEcCtD
Mirabegron—Connective tissue disorder—Epirubicin—ovarian cancer	0.000227	0.00155	CcSEcCtD
Mirabegron—Abdominal pain—Paclitaxel—ovarian cancer	0.000227	0.00155	CcSEcCtD
Mirabegron—Urethral disorder—Epirubicin—ovarian cancer	0.000227	0.00154	CcSEcCtD
Mirabegron—Sinusitis—Doxorubicin—ovarian cancer	0.000223	0.00152	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000222	0.00151	CcSEcCtD
Mirabegron—Erythema multiforme—Epirubicin—ovarian cancer	0.000218	0.00149	CcSEcCtD
Mirabegron—ABCB1—testis—ovarian cancer	0.000216	0.00776	CbGeAlD
Mirabegron—Eye disorder—Epirubicin—ovarian cancer	0.000216	0.00147	CcSEcCtD
Mirabegron—Cardiac disorder—Epirubicin—ovarian cancer	0.000214	0.00146	CcSEcCtD
Mirabegron—Rhinitis—Doxorubicin—ovarian cancer	0.000214	0.00146	CcSEcCtD
Mirabegron—Dyspepsia—Docetaxel—ovarian cancer	0.000214	0.00146	CcSEcCtD
Mirabegron—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000211	0.00144	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00021	0.00143	CcSEcCtD
Mirabegron—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00021	0.00143	CcSEcCtD
Mirabegron—Fatigue—Docetaxel—ovarian cancer	0.00021	0.00143	CcSEcCtD
Mirabegron—Urethral disorder—Doxorubicin—ovarian cancer	0.00021	0.00143	CcSEcCtD
Mirabegron—Constipation—Docetaxel—ovarian cancer	0.000208	0.00142	CcSEcCtD
Mirabegron—Asthenia—Paclitaxel—ovarian cancer	0.000206	0.0014	CcSEcCtD
Mirabegron—Pruritus—Paclitaxel—ovarian cancer	0.000203	0.00138	CcSEcCtD
Mirabegron—Erythema multiforme—Doxorubicin—ovarian cancer	0.000202	0.00138	CcSEcCtD
Mirabegron—Eye disorder—Doxorubicin—ovarian cancer	0.0002	0.00136	CcSEcCtD
Mirabegron—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000199	0.00136	CcSEcCtD
Mirabegron—Cardiac disorder—Doxorubicin—ovarian cancer	0.000198	0.00135	CcSEcCtD
Mirabegron—Diarrhoea—Paclitaxel—ovarian cancer	0.000196	0.00134	CcSEcCtD
Mirabegron—Back pain—Epirubicin—ovarian cancer	0.000195	0.00133	CcSEcCtD
Mirabegron—Abdominal pain—Docetaxel—ovarian cancer	0.000192	0.00131	CcSEcCtD
Mirabegron—Dizziness—Paclitaxel—ovarian cancer	0.00019	0.00129	CcSEcCtD
Mirabegron—Vision blurred—Epirubicin—ovarian cancer	0.00019	0.00129	CcSEcCtD
Mirabegron—Rash—Paclitaxel—ovarian cancer	0.000181	0.00123	CcSEcCtD
Mirabegron—Dermatitis—Paclitaxel—ovarian cancer	0.000181	0.00123	CcSEcCtD
Mirabegron—Back pain—Doxorubicin—ovarian cancer	0.00018	0.00123	CcSEcCtD
Mirabegron—Headache—Paclitaxel—ovarian cancer	0.00018	0.00123	CcSEcCtD
Mirabegron—Palpitations—Epirubicin—ovarian cancer	0.000178	0.00121	CcSEcCtD
Mirabegron—Vision blurred—Doxorubicin—ovarian cancer	0.000175	0.00119	CcSEcCtD
Mirabegron—Asthenia—Docetaxel—ovarian cancer	0.000175	0.00119	CcSEcCtD
Mirabegron—Hypertension—Epirubicin—ovarian cancer	0.000174	0.00118	CcSEcCtD
Mirabegron—Pruritus—Docetaxel—ovarian cancer	0.000172	0.00117	CcSEcCtD
Mirabegron—Arthralgia—Epirubicin—ovarian cancer	0.000171	0.00117	CcSEcCtD
Mirabegron—Nausea—Paclitaxel—ovarian cancer	0.000171	0.00116	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00017	0.00116	CcSEcCtD
Mirabegron—Dry mouth—Epirubicin—ovarian cancer	0.000167	0.00114	CcSEcCtD
Mirabegron—Diarrhoea—Docetaxel—ovarian cancer	0.000167	0.00113	CcSEcCtD
Mirabegron—Palpitations—Doxorubicin—ovarian cancer	0.000164	0.00112	CcSEcCtD
Mirabegron—Infection—Epirubicin—ovarian cancer	0.000163	0.00111	CcSEcCtD
Mirabegron—Dizziness—Docetaxel—ovarian cancer	0.000161	0.0011	CcSEcCtD
Mirabegron—Hypertension—Doxorubicin—ovarian cancer	0.000161	0.00109	CcSEcCtD
Mirabegron—Tachycardia—Epirubicin—ovarian cancer	0.00016	0.00109	CcSEcCtD
Mirabegron—Skin disorder—Epirubicin—ovarian cancer	0.000159	0.00109	CcSEcCtD
Mirabegron—Arthralgia—Doxorubicin—ovarian cancer	0.000158	0.00108	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000157	0.00107	CcSEcCtD
Mirabegron—ABCB1—lymph node—ovarian cancer	0.000157	0.00562	CbGeAlD
Mirabegron—Dry mouth—Doxorubicin—ovarian cancer	0.000155	0.00106	CcSEcCtD
Mirabegron—Rash—Docetaxel—ovarian cancer	0.000153	0.00105	CcSEcCtD
Mirabegron—Dermatitis—Docetaxel—ovarian cancer	0.000153	0.00104	CcSEcCtD
Mirabegron—Headache—Docetaxel—ovarian cancer	0.000152	0.00104	CcSEcCtD
Mirabegron—Infection—Doxorubicin—ovarian cancer	0.000151	0.00103	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00015	0.00102	CcSEcCtD
Mirabegron—Tachycardia—Doxorubicin—ovarian cancer	0.000148	0.00101	CcSEcCtD
Mirabegron—Skin disorder—Doxorubicin—ovarian cancer	0.000148	0.00101	CcSEcCtD
Mirabegron—Nausea—Docetaxel—ovarian cancer	0.000145	0.000985	CcSEcCtD
Mirabegron—Dyspepsia—Epirubicin—ovarian cancer	0.000145	0.000984	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000142	0.000966	CcSEcCtD
Mirabegron—Fatigue—Epirubicin—ovarian cancer	0.000142	0.000964	CcSEcCtD
Mirabegron—Constipation—Epirubicin—ovarian cancer	0.00014	0.000956	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000138	0.000943	CcSEcCtD
Mirabegron—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000134	0.000915	CcSEcCtD
Mirabegron—Dyspepsia—Doxorubicin—ovarian cancer	0.000134	0.000911	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000131	0.000893	CcSEcCtD
Mirabegron—Fatigue—Doxorubicin—ovarian cancer	0.000131	0.000892	CcSEcCtD
Mirabegron—Urticaria—Epirubicin—ovarian cancer	0.00013	0.000888	CcSEcCtD
Mirabegron—Constipation—Doxorubicin—ovarian cancer	0.00013	0.000885	CcSEcCtD
Mirabegron—Abdominal pain—Epirubicin—ovarian cancer	0.00013	0.000884	CcSEcCtD
Mirabegron—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000124	0.000846	CcSEcCtD
Mirabegron—Urticaria—Doxorubicin—ovarian cancer	0.000121	0.000822	CcSEcCtD
Mirabegron—Abdominal pain—Doxorubicin—ovarian cancer	0.00012	0.000818	CcSEcCtD
Mirabegron—Asthenia—Epirubicin—ovarian cancer	0.000118	0.000802	CcSEcCtD
Mirabegron—Pruritus—Epirubicin—ovarian cancer	0.000116	0.000791	CcSEcCtD
Mirabegron—Diarrhoea—Epirubicin—ovarian cancer	0.000112	0.000765	CcSEcCtD
Mirabegron—Asthenia—Doxorubicin—ovarian cancer	0.000109	0.000742	CcSEcCtD
Mirabegron—Dizziness—Epirubicin—ovarian cancer	0.000109	0.00074	CcSEcCtD
Mirabegron—Pruritus—Doxorubicin—ovarian cancer	0.000107	0.000732	CcSEcCtD
Mirabegron—Diarrhoea—Doxorubicin—ovarian cancer	0.000104	0.000708	CcSEcCtD
Mirabegron—Rash—Epirubicin—ovarian cancer	0.000104	0.000705	CcSEcCtD
Mirabegron—Dermatitis—Epirubicin—ovarian cancer	0.000103	0.000705	CcSEcCtD
Mirabegron—Headache—Epirubicin—ovarian cancer	0.000103	0.000701	CcSEcCtD
Mirabegron—Dizziness—Doxorubicin—ovarian cancer	0.0001	0.000684	CcSEcCtD
Mirabegron—Nausea—Epirubicin—ovarian cancer	9.75e-05	0.000664	CcSEcCtD
Mirabegron—Rash—Doxorubicin—ovarian cancer	9.58e-05	0.000652	CcSEcCtD
Mirabegron—Dermatitis—Doxorubicin—ovarian cancer	9.57e-05	0.000652	CcSEcCtD
Mirabegron—Headache—Doxorubicin—ovarian cancer	9.52e-05	0.000648	CcSEcCtD
Mirabegron—Nausea—Doxorubicin—ovarian cancer	9.02e-05	0.000615	CcSEcCtD
